Günther Köhler, MD, PhD

Articles by Günther Köhler, MD, PhD

Paclitaxel and Epirubicin as First-Line Therapy for Patients With Metastatic Breast Cancer

ByHans-Joachim Lück, MD,Andreas Du Bois, MD, PhD,Christoph Thomssen, MD, PhD,Björn Lisboa, MD, PhD,Michael Untch, MD, PhD,Günther Köhler, MD, PhD,Detlev Hecker, PhD,Klaus Diergarten, MD

Paclitaxel (Taxol) has aroused considerable interest for its high single-agent activity in breast cancer and novel mechanism of action. Epirubicin (Farmorubicin), the 4'epimer of doxorubicin (Adriamycin), also has high activity in

Latest Updated Articles